Literature DB >> 8159769

The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage.

S Hatakeyama1, K Iwabuchi, K Ogasawara, R A Good, K Onoé.   

Abstract

The c-fgr gene is a member of the Src family of protooncogene tyrosine kinases. A monoclonal antibody (2H2) that recognizes the specific region of the N-terminal domain of the murine c-fgr gene product (Fgr) has been established. With an immune complex kinase assay in a monocytic leukemia cell line, 2H2 monoclonal antibody was shown to precipitate a 59-kDa protein that corresponds in molecular mass to murine Fgr. Fgr was expressed highly in lymph nodes, slightly in spleen and peripheral blood leukocytes, and barely in the thymus and was not detected in bone marrow. In the presence of a mild detergent, Fgr was coimmunoprecipitated with a 70-kDa protein (p70) or with p70 plus several other molecules that were expressed on the cell-surface membrane of macrophage tumor cell lines PU5-1.8 and J774.1, respectively. By contrast, Fgr was not coimmunoprecipitated with a low-affinity receptor for the Fc portion of IgG that is associated with human Fgr. The molecule was also coimmunoprecipitated with the Ly6C molecule from a macrophage cell line (J774.1) that showed protein-tyrosine kinase activity. Peptide mapping revealed that this kinase activity was derived from Fgr. The similarity of relationship between this intramembrane p70 and/or Ly6C and cytoplasmic Fgr to relationships previously reported between T-cell antigen receptor complex, including CD4 and CD8 coreceptors, and Lck or Fyn in T cells and between surface IgM and Lyn or Blk in B cells, suggests that the Fgr and p70 or Ly6C are, indeed, associated with each other and in the murine system may be responsible for recognition of extracellular substances (either cellular or noncellular) and for signal transduction in cells of monocyte/macrophage lineage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159769      PMCID: PMC43596          DOI: 10.1073/pnas.91.8.3458

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Association of B cell antigen receptor with protein tyrosine kinase Lyn.

Authors:  Y Yamanashi; T Kakiuchi; J Mizuguchi; T Yamamoto; K Toyoshima
Journal:  Science       Date:  1991-01-11       Impact factor: 47.728

2.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor.

Authors:  L E Samelson; A F Phillips; E T Luong; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.

Authors:  S M Dymecki; J E Niederhuber; S V Desiderio
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

4.  Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn).

Authors:  M P Cooke; K M Abraham; K A Forbush; R M Perlmutter
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

5.  Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases.

Authors:  A L Burkhardt; M Brunswick; J B Bolen; J J Mond
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.

Authors:  I Stefanová; V Horejsí; I J Ansotegui; W Knapp; H Stockinger
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

7.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.

Authors:  M Hatakeyama; T Kono; N Kobayashi; A Kawahara; S D Levin; R M Perlmutter; T Taniguchi
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

8.  Specific expression of human c-fgr in natural immunity effector cells.

Authors:  K Inoue; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

9.  Translocation of the FGR protein-tyrosine kinase as a consequence of neutrophil activation.

Authors:  J S Gutkind; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Accumulation of p60lck in HTLV-I-transformed T cell lines detected by an anti-lck monoclonal antibody, MOL 171.

Authors:  Y Moroi; Y Koga; K Nakamura; M Ohtsu; G Kimura; K Nomoto
Journal:  Jpn J Cancer Res       Date:  1991-08
View more
  9 in total

1.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

2.  Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes.

Authors:  S Ilangumaran; S Arni; G van Echten-Deckert; B Borisch; D C Hoessli
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

3.  Stress- and aging-associated modulation of macrophage functions.

Authors:  Takako Kizaki; Kenji Suzuki; Tomomi Ookawara; Tetsuya Izawa; Daizoh Saitoh; Shuji Oh-Ishi; Keiichiro Suzuki; Shukoh Haga; Hideki Ohno
Journal:  Environ Health Prev Med       Date:  2002-01       Impact factor: 3.674

4.  CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.

Authors:  Rukiye-Nazan E Dogan; Nancy Long; Eileen Forde; Kristen Dennis; Adam P Kohm; Stephen D Miller; William J Karpus
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

5.  Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts.

Authors:  Elizabeth Delorme-Axford; Yoel Sadovsky; Carolyn B Coyne
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

6.  Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.

Authors:  Céline Cougoule; Maik Drechsler; Indira Medina; Beatriz Bermudez; Rory R Koenen; Judith Sluimer; Ine Wolfs; Yvonne Döring; Veronica Herias; Marjon Gijbels; Ilze Bot; Saskia de Jager; Christian Weber; Jack Cleutjens; Theo J C van Berkel; Kees-Jan Sikkink; Atilla Mócsai; Isabelle Maridonneau-Parini; Oliver Soehnlein; Erik A L Biessen
Journal:  Circulation       Date:  2015-06-11       Impact factor: 29.690

7.  CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection.

Authors:  Matthew A Fischer; Michael L Davies; Irene E Reider; Erica L Heipertz; Melanie R Epler; Janet J Sei; Molly A Ingersoll; Nico Van Rooijen; Gwendalyn J Randolph; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

8.  Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma.

Authors:  Qiangqiang Zhao; Duanfeng Jiang; Xiaoying Sun; Qiuyu Mo; Shaobin Chen; Wansong Chen; Rong Gui; Xianjun Ma
Journal:  J Nanobiotechnology       Date:  2021-06-13       Impact factor: 10.435

Review 9.  Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells.

Authors:  Dimitry A Chistiakov; Dmitry A Kashirskikh; Victoriya A Khotina; Andrey V Grechko; Alexander N Orekhov
Journal:  J Clin Med       Date:  2019-10-27       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.